Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 3542149, 13 pages
https://doi.org/10.1155/2017/3542149
Research Article

Inhibition of Caveolae Contributes to Propofol Preconditioning-Suppressed Microvesicles Release and Cell Injury by Hypoxia-Reoxygenation

1Department of Anesthesiology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China
2Department of Anesthesiology, Taihe Hospital, Hubei University of Medicine, Anesthesiology Research Institute of Hubei University of Medicine, Shiyan, Hubei Province, China
3Department of Anesthesiology, Dongfeng General Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China
4Key Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital & Institute, Guangzhou Medical University, Guangzhou 511436, China
5Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Institute of Neurology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong, China

Correspondence should be addressed to Du Feng; moc.liamxof@ud_gnef and Liangqing Zhang; moc.361@0791qlgnahz

Received 7 June 2017; Accepted 6 August 2017; Published 19 September 2017

Academic Editor: Hong Zheng

Copyright © 2017 Fan Deng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Yu, H. Zhang, W. Zhao et al., “Gypenoside protects against myocardial ischemia-reperfusion injury by inhibiting cardiomyocytes apoptosis via inhibition of CHOP pathway and activation of PI3K/Akt pathway in vivo and in vitro,” Cellular Physiology and Biochemistry, vol. 39, no. 1, pp. 123–136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Wu, J. Wang, H. Li, M. Xue, A. Ji, and Y. Li, “Role of hydrogen sulfide in ischemia-reperfusion injury,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 186908, 16 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Chen, W. Chen, Z. Nong, Y. Ma, S. Qiu, and G. Wu, “Cardioprotective effects of combined therapy with hyperbaric oxygen and diltiazem pretreatment on myocardial ischemia-reperfusion injury in rats,” Cellular Physiology and Biochemistry, vol. 38, no. 5, pp. 2015–2029, 2016. View at Publisher · View at Google Scholar
  4. T. Zhou, C. C. Chuang, and L. Zuo, “Molecular characterization of reactive oxygen species in myocardial ischemia-reperfusion injury,” BioMed Research International, vol. 2015, Article ID 864946, 9 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. R. S. Ferrari and C. F. Andrade, “Oxidative stress and lung ischemia-reperfusion injury,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 590987, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Zhu, Q. Yao, X. Hu, C. Chen, H. Yao, and J. Chao, “The role of MCPIP1 in ischemia/reperfusion injury-induced HUVEC migration and apoptosis,” Cellular Physiology and Biochemistry, vol. 37, no. 2, pp. 577–591, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. X. L. Yang Wang, X. Wang, W. Lau et al., “Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway,” PLoS One, vol. 8, no. 8, 2013. View at Publisher · View at Google Scholar
  8. A. A. Constantinescu, M. Abbas, M. Kassem et al., “Differential influence of tacrolimus and sirolimus on mitochondrial-dependent signaling for apoptosis in pancreatic cells,” Molecular and Cellular Biochemistry, vol. 418, no. 1-2, pp. 91–102, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Deng, T. Deng, Y. Ni et al., “Cytochrome c modulates the mitochondrial signaling pathway and polymorphonuclear neutrophil apoptosis in bile duct-ligated rats,” Experimental and Therapeutic Medicine, vol. 12, no. 1, pp. 333–342, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Zeng, S. H. Lai, J. H. Yao et al., “The induction of apoptosis in HepG-2 cells by ruthenium(II) complexes through an intrinsic ROS-mediated mitochondrial dysfunction pathway,” European Journal of Medicinal Chemistry, vol. 122, pp. 118–126, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Buendia, A. M. de Oca, J. A. Madueño et al., “Endothelial microparticles mediate inflammation-induced vascular calcification,” The FASEB Journal, vol. 29, no. 1, pp. 173–181, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Schiro, F. L. Wilkinson, R. Weston, J. V. Smyth, F. Serracino-Inglott, and M. Y. Alexander, “Endothelial microparticles as conveyors of information in atherosclerotic disease,” Atherosclerosis, vol. 234, no. 2, pp. 295–302, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. A. F. Tramontano, R. Lyubarova, J. Tsiakos, T. Palaia, J. R. Deleon, and L. Ragolia, “Circulating endothelial microparticles in diabetes mellitus,” Mediators of Inflammation, vol. 2010, Article ID 250476, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Andriantsitohaina, A. Gaceb, L. Vergori, and M. C. Martinez, “Microparticles as regulators of cardiovascular inflammation,” Trends in Cardiovascular Medicine, vol. 22, no. 4, pp. 88–92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. H. N. Fridolfsson and H. H. Patel, “Caveolin and caveolae in age associated cardiovascular disease,” Journal of Geriatric Cardiology, vol. 10, no. 1, pp. 66–74, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. H. H. Patel, F. Murray, and P. A. Insel, “Caveolae as organizers of pharmacologically relevant signal transduction molecules,” Annual Review of Pharmacology and Toxicology, vol. 48, pp. 359–391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. W. Kang and S. M. Lee, “Impaired expression of caveolin-1 contributes to hepatic ischemia and reperfusion injury,” Biochemical and Biophysical Research Communications, vol. 450, no. 4, pp. 1351–1357, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Das, M. Gherghiceanu, I. Lekli, S. Mukherjee, L. M. Popescu, and D. K. Das, “Essential role of lipid raft in ischemic preconditioning,” Cellular Physiology and Biochemistry, vol. 21, no. 4, pp. 325–334, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. W. FAN, X. Zhu, L. Wu et al., “Propofol: an anesthetic possessing neuroprotective effects,” European Review for Medical and Pharmacological Sciences, vol. 19, no. 8, pp. 1520–1529, 2015. View at Google Scholar
  20. S. Lemoine, L. Zhu, S. Gress, J. L. Gerard, S. Allouche, and J. L. Hanouz, “Mitochondrial involvement in propofol-induced cardioprotection: an in vitro study in human myocardium,” Experimental Biology and Medicine, vol. 241, no. 5, pp. 527–538, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. Z. Chen, Z. Hu, Z. Lu et al., “Differential microRNA profiling in a cellular hypoxia reoxygenation model upon posthypoxic propofol treatment reveals alterations in autophagy signaling network,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 378484, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Jiang, Z. Zhou, Q. T. Meng et al., “Ginsenoside Rb1 treatment attenuates pulmonary inflammatory cytokine release and tissue injury following intestinal ischemia reperfusion injury in mice,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 843721, 12 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Liu, J. Jin, S. Qiao et al., “Inhibition of PKCβ2 overexpression ameliorates myocardial ischaemia/reperfusion injury in diabetic rats via restoring caveolin-3/Akt signaling,” Clinical Science, vol. 129, no. 4, pp. 331–344, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Combes, A. C. Simon, G. E. Grau et al., “In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant,” The Journal of Clinical Investigation, vol. 104, pp. 93–102, 1999. View at Publisher · View at Google Scholar
  25. K. R. Paudel, N. Panth, and D. W. Kim, “Circulating endothelial microparticles: a key hallmark of atherosclerosis progression,” Scientifica, vol. 2016, Article ID 8514056, 9 pages, 2016. View at Publisher · View at Google Scholar
  26. R. A. Dragovic, C. Gardiner, A. S. Brooks et al., “Sizing and phenotyping of cellular vesicles using nanoparticle tracking analysis,” Nanomedicine, vol. 7, no. 6, pp. 780–788, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. H. A. Awad, A. A. Tantawy, R. A. El-Farrash, E. A. Ismail, and N. M. Youssif, “CD144+ endothelial microparticles as a marker of endothelial injury in neonatal ABO blood group incompatibility,” Blood Transfusion, vol. 12, no. 2, pp. 250–259, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Dignat-George and C. Boulanger, “The many faces of endothelial microparticles,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 1, pp. 27–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. Q. Pan, C. He, H. Liu et al., “Microvascular endothelial cells-derived microvesicles imply in ischemic stroke by modulating astrocyte and blood brain barrier function and cerebral blood flow,” Molecular Brain, vol. 9, no. 1, p. 63, 2016. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Wang, Y. Li, X. Song et al., “Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis,” Journal of Translational Medicine, vol. 13, p. 209, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. L. L. Meng Zhang, S.-J. Lee, L. Mo, J. Cao, E. Ifedigbo, and Y. Jin, “Deletion of caveolin-1 protects hyperoxia-induced apoptosis via survivin-mediated pathways,” American Journal of Physiology. Lung Cellular and Molecular Physiology, vol. 297, pp. L945–L953, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Mezentsev, R. M. Merks, E. O'Riordan et al., “Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress,” American Journal of Physiology. Heart and Circulatory Physiology, vol. 289, pp. H1106–H1114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. W. Li, H. Liu, J. S. Zhou et al., “Caveolin-1 inhibits expression of antioxidant enzymes through direct interaction with nuclear erythroid 2 p45-related factor-2 (Nrf2),” The Journal of Biological Chemistry, vol. 287, no. 25, pp. 20922–20930, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Zhang, Y. Liu, Z. Zhao, and Y. Xue, “Effects of green tea polyphenols on caveolin-1 of microvessel fragments in rats with cerebral ischemia,” Neurological Research, vol. 32, no. 9, pp. 963–970, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Huang, C. M. Zhou, Y. Y. Liu et al., “Cerebralcare granule® attenuates blood-brain barrier disruption after middle cerebral artery occlusion in rats,” Experimental Neurology, vol. 237, no. 2, pp. 453–463, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. Z. Xia, D. V. Godin, and D. M. Ansley, “Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F2t-isoprostane formation and tissue antioxidant capacity,” Cardiovascular Research, vol. 59, no. 1, pp. 113–121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Li, D. Zhong, L. Lei, Y. Jia, H. Zhou, and B. Yang, “Propofol prevents renal ischemia-reperfusion injury via inhibiting the oxidative stress pathways,” Cellular Physiology and Biochemistry, vol. 37, no. 1, pp. 14–26, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. R. V. Vince, B. Chrismas, A. W. Midgley, L. R. McNaughton, and L. A. Madden, “Hypoxia mediated release of endothelial microparticles and increased association of S100A12 with circulating neutrophils,” Oxidative Medicine and Cellular Longevity, vol. 2, no. 1, pp. 2–6, 2009. View at Publisher · View at Google Scholar
  39. F. Sabatier, P. Darmon, B. Hugel et al., “Type 1 and type 2 diabetic patients display different patterns of cellular microparticles,” Diabetes, vol. 51, pp. 2840–2845, 2002. View at Publisher · View at Google Scholar
  40. S. Bernard, R. Loffroy, A. Sérusclat et al., “Increased levels of endothelial microparticles CD144 (VE-cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT),” Atherosclerosis, vol. 203, no. 2, pp. 429–435, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Couet, M. M. Belanger, E. Roussel, and M. C. Drolet, “Cell biology of caveolae and caveolin,” Advanced Drug Delivery Reviews, vol. 49, pp. 223–235, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Morello, V. R. Minciacchi, P. de Candia et al., “Large oncosomes mediate intercellular transfer of functional microRNA,” Cell Cycle, vol. 12, no. 22, pp. 3526–3536, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. L. Gao, X. Chen, T. Peng et al., “Caveolin-1 protects against hepatic ischemia/reperfusion injury through ameliorating peroxynitrite-mediated cell death,” Free Radical Biology and Medicine, vol. 95, pp. 209–215, 2016. View at Publisher · View at Google Scholar · View at Scopus